CSF1 treatment induced a significantly higher percentage of F4/80+/Tie2+ TEMs (p = 0.0003) than the percentage of overall tumor F4/80+ cells (Figure 4A) while a neutralizing antibody to CSF1R abrogated this effect. The gene discussed is CSF1R; the disease is neoplasm.